Jupiter Research Capital (Asia) Ltd’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$14.4M Buy
+74,918
New +$8.07M 1.59% 7
2026
Q2
– Sell
-216,889
Closed -$11M – 976
2026
Q1
$11M Buy
+216,889
New +$10.1M 1.22% 10

Other funds holding MRNA

Jupiter Research Capital (Asia) Ltd's MRNA Position: Q3 2026 in Review

Jupiter Research Capital (Asia) Ltd opened a new position in Moderna (MRNA) in Q3 2026: 74,918 shares worth $14.4M. The stake represents 1.59% of the portfolio and ranks #7 among its holdings. This is a return to the name: Jupiter Research Capital (Asia) Ltd previously reported a position in MRNA as recently as Q1 2026.

Jupiter Research Capital (Asia) Ltd first reported a position in MRNA in Q1 2026 and has held it in 2 quarters since. 972 funds tracked by Wall St. Rank hold MRNA as of Q3 2026.

  • Jupiter Research Capital (Asia) Ltd held 74,918 shares of Moderna worth $14.4M as of Q3 2026.
  • Moderna was a new Jupiter Research Capital (Asia) Ltd position in Q3 2026.
  • Moderna made up 1.59% of Jupiter Research Capital (Asia) Ltd's portfolio in Q3 2026, its #7 holding.
  • Jupiter Research Capital (Asia) Ltd first reported a position in Moderna in Q1 2026 and has held it in 2 quarters since.
  • 972 funds tracked by Wall St. Rank held Moderna as of Q3 2026.

Based on Jupiter Research Capital (Asia) Ltd's 13F filing for Q3 2026, filed 16 Nov 2026.